安省ICU爆满 降低重症患者死亡率的药供应告急

不要想当然： Remdesivir was authorized with conditions in Canada on July 27, 2020. It was authorized for the treatment of severe COVID-19 in adults and youth (aged 12 years and over and weighing at least 40 kg) with pneumonia requiring supplemental oxygen. https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/remdesivir-update.html#:~:text=Remdesivir%20was%20authorized%20with%20conditions,pneumonia%20requiring%20supplemental%20oxygen.